21st Dec 2020 17:07
Arix Bioscience PLC - venture capital firm investing in biotech companies - Executive Chair Naseem Amin buys 183,000 shares via Davum Capital Ltd at 206.00 pence, worth GBP376,980, on Friday last week. Arix also notes that Merck & Co Inc completed the purchase of Arix investee VelosBio Inc for USD2.75 billion. The transaction generates USD187.0 million in gross proceeds for Arix, a 12.5-times return on its original investment of USD15.0 million.
Current stock price: 202.00p
Year-to-date change: almost doubled from 106.50p on December 31, 2019
By Tom Waite; [email protected]
Copyright 2020 Alliance News Limited. All Rights Reserved.
Related Shares:
ARIX.L